AdvaMed®
  • Our Work
    • Key Issues
    • Policy Areas
    • Sectors
    • Emerging Policy & Tariff Response Center
    • Annual Report
  • Industry Updates
    • Research & Policy Papers
    • Medtech POV with Scott Whitaker
    • Medtech POV Blog
    • Press Releases
  • Join
  • Member Center
    • Committees & Working Groups
    • Resource Library
    • Medtech Career Center
  • Events & Education
    • All Events & Education
    • In Person
    • Online
Login
first page of letter
Coverage & Payment

AdvaMed® Submits Comments on CY 2023 ESRD PPS Proposed Rule

AdvaMed® submitted comments to CMS the CY 2023 End Stage Renal Disease (ESRD) Prospective Payment System.

first page of letter
Coverage & Payment / Diagnostics

AdvaMed® Submits Comments on Genetic Testing in Oncology LCD

AdvaMed® submitted a letter to Medicare Administrative Contractors, Novitas and First Coast Service Options, regarding proposed LCDs on Genetic Testing in Oncology.

first page of letter
Coverage & Payment

AdvaMed® Submits Comments on FY 2023 IPPS Proposed Rule

AdvaMed® submitted comments to CMS on the Fiscal Year 2023 Hospital Inpatient Prospective Payment System proposed rule.

first page of letter
Coverage & Payment / Radiation Therapy

AdvaMed® Comments on Proposed Delay of Radiation Oncology Model

AdvaMed® submitted comments to the Center for Medicare and Medicaid Services (CMS) on its Radiation Oncology (RO) Model proposed rule proposing to indefinitely delay the start date of the RO…

first page of letter
Coverage & Payment / Diabetes

AdvaMed® Submits Comments on Local Coverage Determination of Skin Substitutes

AdvaMed® submitted a letter regarding proposed local coverage determinations entitled “Skin Substitutes for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcer.”

first page of AdvaMed® Comments on Proposed CDC Clinical Practice Guideline for Prescribing Opioids
Coverage & Payment

AdvaMed® Comments on Proposed CDC Clinical Practice Guideline for Prescribing Opioids

AdvaMed® urged CDC to recognize the critical role evidence-based and FDA-approved/cleared devices can and should play in improving pain management and reducing opioid-related harms.

first page of letter
Coverage & Payment

AdvaMed® Statements from Centers for Medicare and Medicaid Services Listening Sessions on Transitional Coverage of Emerging Technologies

During two listening sessions, AdvaMed® provided responses to a set of questions posed by CMS on the parameters for a new TCET program, including the types of guidance provided by…

first page of letter
Coverage & Payment

AdvaMed® Responds to HHS Office of the National Coordinator Request for Information on Electronic Prior Authorization Standards

AdvaMed® submitted a response to a Department of Health and Human Services (HHS) Office of the National Coordinator for Health Information Technology (ONC) Request for Information (RFI) on electronic prior…

first page of letter
Coverage & Payment

AdvaMed® Responds to U.S. House of Representatives Health Futures Task Force, Subcommittee on Treatments Request for Information on Fostering Patient Access to Life-Saving Cures

AdvaMed® submitted a response to a U.S. House of Representatives Healthy Futures Task Force, Subcommittee on Treatments (Subcommittee on Treatments) Request for Information (RFI) on information to help foster patient…

first page of letter
Coverage & Payment

AdvaMed® Advocates for Skin Substitute Coding and Coverage Policy Changes in Advance of Annual Rulemaking

AdvaMed® submitted a letter to the Centers for Medicare and Medicaid Services (CMS) regarding coverage and payment policies for skin substitute products as used and paid for in the outpatient…

  • Previous
  • 1
  • 2
  • 3
  • …
  • 5
  • Next
AdvaMed®

Stay up to date with AdvaMed®.

Subscribe for Updates
  • Join
  • Member Center
  • Industry Updates
  • Contact
  • FAQs
  • Events & Education
  • Careers
  • The Story of Medtech
  • The Medtech Conference
  • Because Every Moment Matters 

Copyright 2025 AdvaMed®

  • Sitemap
  • Terms of Use
  • Privacy Policy
  • Accessibility Statement
  • 中文
  • youtube
  • linkedin
  • facebook
  • X
  • medium
  • instagram

Menu

  • Our Work
    • Key Issues
    • Policy Areas
    • Sectors
    • Emerging Policy & Tariff Response Center
    • Annual Report
  • Industry Updates
    • Research & Policy Papers
    • Medtech POV with Scott Whitaker
    • Medtech POV Blog
    • Press Releases
  • Join
  • Member Center
    • Committees & Working Groups
    • Resource Library
    • Medtech Career Center
  • Events & Education
    • All Events & Education
    • In Person
    • Online
  • Login
  • About AdvaMed®
    • Our Leadership
    • Initiatives
    • Jobs at AdvaMed®
    • Contact Us
  • Membership & Join
    • Membership Directory
    • Associate Membership Directory
    • Membership Application
    • Lifetime Achievement Award
  • Medical Device Industry Facts
    • Safety & Quality
    • Job Creation
  • AdvaMed Accel®
    • Accel Member Directory
    • Partnerships and Opportunities
  • AdvaMedDx®
    • AdvaMed®DX Members
    • AdvaMedDx® Resources
    • Join AdvaMed®DX
  • AdvaMed Digital Health Tech™
    • AdvaMed Digital Health Tech™ Members
  • AdvaMed Medical Imaging™
    • AdvaMed Imaging® Members

Search